| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |